Showing results (1-10 of 142) with videos related to
Sort By:
Pageof 15
Physical Review Letters|October 26, 2002
Perturbative QCD analysis of local duality in a fixed w2 frameworkS Liuti, R Ent, C E Keppel, et al.Current Opinion in Investigational Drugs (London, England : 2000)|September 25, 2001
Thymitaq (Zarix)I Niculescu-DuvazIdrugs : the Investigational Drugs Journal|May 10, 2008
Recent advances in anticancer drugsI Niculescu DuvazIdrugs : the Investigational Drugs Journal|July 21, 2005
NCI-EORTC-AACR--11th Symposium on New Drugs in Cancer Therapy: Gene therapy and new drugs. 7-10 November 2000, Amsterdam, The NetherlandsI Niculescu-DuvazCurrent Opinion in Molecular Therapeutics|March 16, 2001
Technology evaluation: gemtuzumab ozogamicin, Celltech GroupI Niculescu-DuvazCurrent Opinion in Investigational Drugs (London, England : 2000)|March 16, 2001
ZD-9331 AstraZenecaI Niculescu-DuvazExpert Opinion on Investigational Drugs|June 1, 1997
Gene-directed enzyme prodrug therapy: a review of enzyme/prodrug combinationsI Niculescu-Duvaz, C J SpringerPhysical Review Letters|April 7, 2010
Confirmation of quark-hadron duality in the neutron F2 structure functionS P Malace, Y Kahn, W Melnitchouk, et al.Anti-Cancer Drug Design|July 1, 1995
Antibody-directed enzyme prodrug therapy (ADEPT) with mustard prodrugsC J Springer, I Niculescu-DuvazJournal of Health Psychology|August 19, 2016
Cognitive dissonance and attitudes toward unpleasant medical screeningsMichael R Ent, Mary A GerendPageof 15